T
Tilman B. Drüeke
Researcher at French Institute of Health and Medical Research
Publications - 415
Citations - 22817
Tilman B. Drüeke is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Kidney disease & Hyperparathyroidism. The author has an hindex of 68, co-authored 413 publications receiving 21471 citations. Previous affiliations of Tilman B. Drüeke include Versailles Saint-Quentin-en-Yvelines University & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
Genesis of atherosclerosis in uremic patients.
TL;DR: No long-term, well-controlled studies are available in this area which would have systematically tested the importance of factors such as high blood pressure, via the use of antihypertensive drugs, or disturbances of lipoprotein metabolism, viaThe use of lipid-lowering medications.
Journal ArticleDOI
Lanthanum carbonate, body lanthanum accumulation and potential liver toxicity
Journal ArticleDOI
New insights into the effects of the protein moiety of oxidized LDL (oxLDL)
Stéphanie Vicca,Ziad A. Massy,Carole Hennequin,Djamel Rihane,Thao Nguyen-Khoa,Tilman B. Drüeke,Bernard Lacour +6 more
TL;DR: In vitro oxidation of LDL by hypochlorous acid in vitro, reflecting increased myeloperoxidase activity in vivo, leads mainly to modifications of apolipoproteins, such that the latter in turn induce high rates of apoptosis in a human monocytic cell line via a caspase-dependent pathway.
Journal ArticleDOI
Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification.
Aurélien Mary,Thibaut Objois,Michel Brazier,Youssef Bennis,Cédric Boudot,Gaëlle Lenglet,Julien Paccou,Jean-Marc Bugnicourt,Gabriel Choukroun,Tilman B. Drüeke,Ziad A. Massy,Ziad A. Massy,Saïd Kamel,Isabelle Six,Romuald Mentaverri +14 more
TL;DR: In this article, the impact of uremic serum on CaSR expression in monocytes (U937 and THP-1 cell lines) was investigated in chronic kidney disease (CKD) and healthy volunteers.
Journal ArticleDOI
Control of Secondary Hyperparathyroidism by Vitamin D Derivatives
TL;DR: The nephrology community is still waiting for the advent of nonhypercalcemic and nonhyperphosphatemic vitamin D analogs with PTH suppressive activity equal to the parent compound calcitriol or its immediate precursor, alfacalcidol.